Biotech Stocks Look Strong Heading into 2020, Analyst Says

With lawmakers debating government control of pricing on some prescription plans and the White House proposing the allowance of certain prescription drugs to be imported from Canada, investors are carefully watching the stock market ahead of the 2020 election to see if drug companies will take a hit.